A tissue-level analysis of the BAX expression in 45 patients with epithelial ovarian cancer showed that patients with higher BAX levels were completely sensitive to chemotherapy, while patients with lower BAX levels were resistant to treatment [32]. This evidence concerns the gene BAX and ovarian carcinoma.